SunTrust Robinson Humphrey Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $54.70 --0%
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 16
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 16
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral with a price target of $68.00 (from $86.00).
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $75.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
- Arkema SA (AKE:FP) (ARKAF) PT Raised to EUR55 at Deutsche Bank
- Evercore ISI Downgrades Darden Restaurants (DRI) to In Line
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
